A A Svistunov Selected Research

sodium luminolate

12/2020

[Administration of the immunomodulatory drug aminodihydrophthalazinedione sodium for prevention of progression pneumonia induced COVID-19].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A A Svistunov Research Topics

Disease

2	Atrial Fibrillation 01/2017 - 01/2016
2	Infections 01/2016 - 01/2015
2	Hypertension (High Blood Pressure) 01/2015 - 01/2014
2	Chronic Renal Insufficiency 01/2015 - 01/2013
2	Poisoning 11/2009 - 01/2009
1	COVID-19 12/2020
1	Coronavirus Infections 12/2020
1	Respiratory Insufficiency (Respiratory Failure) 12/2020
1	Pneumonia (Pneumonitis) 12/2020
1	Hypokinesia (Bradykinesia) 02/2020
1	Cholelithiasis 12/2019
1	Neoplasms (Cancer) 12/2019
1	Iron Deficiencies 12/2018
1	Liver Diseases (Liver Disease) 02/2018
1	Virus Diseases (Viral Diseases) 02/2018
1	Premature Aging 01/2018
1	Peripheral Arterial Disease 01/2017
1	ST Elevation Myocardial Infarction 01/2017
1	Flatulence 01/2017
1	Heart Valve Diseases (Valvular Heart Disease) 01/2017
1	Atherosclerosis 01/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Abdominal Pain (Pain, Abdominal) 01/2017
1	Constipation 01/2017
1	Obesity 01/2017
1	Overweight 01/2017
1	Cardiac Arrhythmias (Arrythmia) 01/2016
1	Hyperplasia 01/2015
1	Hypertrophy 01/2015
1	Inflammation (Inflammations) 01/2015
1	Gastroesophageal Reflux (GERD) 01/2015
1	Echinococcosis (Hydatid Cysts) 01/2015
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2015
1	Disease Progression 01/2015
1	Hyperphosphatemia 01/2015
1	Lung Injury 01/2015
1	Nephrolithiasis 05/2010
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2009

Drug/Important Bio-Agent (IBA)

2	LipidsIBA 01/2017 - 01/2017
2	AnticoagulantsIBA 01/2017 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 05/2010
2	Phosphates (Orthophosphate)IBA 01/2013 - 11/2009
2	CytokinesIBA 11/2009 - 01/2009
1	SodiumIBA 12/2020
1	sodium luminolateIBA 12/2020
1	Pharmaceutical PreparationsIBA 12/2020
1	Verapamil (Calan)FDA LinkGeneric 02/2020
1	Cardiovascular AgentsIBA 02/2020
1	Propranolol (Inderal)FDA LinkGeneric 02/2020
1	ethacizineIBA 02/2020
1	MineralsIBA 12/2018
1	IronIBA 12/2018
1	VitaminsIBA 12/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	Psyllium (Metamucil)IBA 01/2017
1	Lipoproteins (Lipoprotein)IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	BariumIBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Endothelial Growth FactorsIBA 01/2015
1	ImmunosorbentsIBA 01/2015
1	Glycoproteins (Glycoprotein)IBA 01/2015
1	IodineIBA 01/2015
1	Glucagon (Glukagon)FDA Link 01/2015
1	EnzymesIBA 01/2015
1	Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA 01/2015
1	Parathyroid Hormone (Parathormone)IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2015
1	Capsules (Microcapsules)IBA 01/2015
1	Fibroblast Growth Factor-23IBA 01/2015
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2015
1	Antihypertensive Agents (Antihypertensives)IBA 01/2014
1	CalciumIBA 01/2013
1	Phosphorus (Red Phosphorus)IBA 01/2013
1	Sevelamer (RenaGel)FDA Link 01/2013
1	Interleukin-6 (Interleukin 6)IBA 05/2010
1	Organophosphorus CompoundsIBA 11/2009
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2009

Therapy/Procedure

7	Therapeutics 12/2020 - 01/2009
1	Oral Administration 02/2020
1	Cholecystectomy 12/2019
1	Drug Therapy (Chemotherapy) 02/2018
1	Percutaneous Coronary Intervention 01/2017
1	Thrombolytic Therapy 01/2017
1	Gastrectomy 01/2015
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 05/2010